Shuimu is the first Asia-Pacific origined commercial cryo-EM drug discovery platform and now owns five latest generations of 300kV cryo-EMs, becoming one of the largest high-end cryo-EM platform industrially accessible.

Strategically partnering with Thermo Fisher Scientific and NVDIA, we equip ourselves with the most advanced microscopes and a powerful computing platform to ensure the high-quality & throughput of our services.

Either you are from pharma/biotech or academic sector, Shuimu's powerful cryo-EM platform will be your go-to choice for high-quality structure determination and structure-based drug discovery projects.